eISSN 2508-3589
pISSN 2508-1926

Table. 5.

Table. 5.

Mean changes in BCVA, CMT, and IOP according to kind of injection (perfusion type)

Feature Group A (n = 6) Group B (n = 7) Group C (n = 30) p-value * Post-hoc test
Mean change in BCVA (logMAR) 0.180 ± 0.06 0.214 ± 0.12 0.083 ± 0.04 0.359 1.000†, 0.435‡, 0.186§
Mean change in CMT (μm) 315.0 ± 63.8 286.4 ± 90.5 205.0 ± 32.8 0.288 0.945†, 0.391‡, 0.146§
Mean change in IOP (mmHg) 0.8 ± 0.8 -2.4 ± 1.1 -1.1 ± 0.7 0.104 0.051†, 0.199‡, 0.159§

Values are presented as mean ± standard deviation. Group A refers to the dexamethasone implant injection arm. Group B refers to the bevacizumab to dexamethasone implant injection arm. Group C refers to the bevacizumab injection arm.

BCVA = best corrected visual acuity; logMAR = logarithm of minimal angle of resolution; CMT = central macular thickness; IOP = intraocular pressure.

* p-value for three-group comparison by the Kruskal-Wallis test; † Comparison between Groups A and B; ‡ Comparison between Groups B and C; §Comparison between Groups A and C.
J Retin 2020;5:135-42 https://doi.org/10.21561/jor.2020.5.2.135
© 2020 J Retin